Our orphan drug designations prevent AZ or any pharma from actively marketing Exenatide for IIH. But what prevents a doctor from prescribing Byetta or Bydureon off-label for IIH? Doctors prescribe off-label all the time.
Is it just the fact that those drugs cost USD 500 per month and insurance won't pay for off-label use? So the only patients who would ask for Byetta and Bydureon are uninsured patients?
IXC Price at posting:
70.5¢ Sentiment: Hold Disclosure: Held
